Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

193
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
193
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

269
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
269
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

173
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
173
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

250
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
250
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

2.8K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.8K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

397
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
397

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Role of the skilled nursing facility in Clostridioides difficile infection transitions of care: A retrospective cohort study of US hospitals.

American journal of infection control·2026
Same author

Safety and Efficacy of Fecal Microbiota, Live-jslm, in Preventing Recurrent <i>Clostridioides difficile</i> Infection in Participants Who Were Mildly to Moderately Immunocompromised in the Phase 3 PUNCH CD3-OLS Study.

Open forum infectious diseases·2025
Same author

Comment on: Community-acquired pneumonia: a US perspective on the guideline gap.

The Journal of antimicrobial chemotherapy·2024
Same author

Microbiota restoration therapies for recurrent <i>Clostridioides difficile</i> infection reach an important new milestone.

Therapeutic advances in gastroenterology·2024
Same author

Effect of Fecal Microbiota, Live-Jslm (REBYOTA [RBL]) on Health-Related Quality of Life in Patients With Recurrent <i>Clostridioides difficile</i> Infection: Results From the PUNCH CD3 Clinical Trial.

Open forum infectious diseases·2023
Same author

The Nation's Promise of Care.

Professional case management·2023

Related Experiment Video

Updated: Aug 26, 2025

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

9.1K

Reducing Recurrence and Complications Related to Clostridioides difficile Infection: A Panel Discussion Summary.

Rebecca Perez1,2,3,4,5,6,7,8, Sahill Khanna1,2,3,4,5,6,7,8, Glenn S Tillotson1,2,3,4,5,6,7,8

  • 1Rebecca Perez, MSN, RN, CCM, is an experienced RN with a master's degree in nursing, is a Certified Case Manager, and a member of the Gamma Omega Chapter of Sigma Theta Tau International Nursing Honor Society and Capella University National Society of Leadership and Success. She is the author of numerous professional articles, the primary author for the Case Management Adherence Guide 2020, co-author of CMSA's Integrated Case Management: A manual for case managers by case managers , developer of the Integrated Case Management Training Program, and Master Trainer. She joined Parthenon Management Group in 2020 as the Senior Manager of Education and Strategic Partnerships for the Case Management Society of America.

Professional Case Management
|October 7, 2022
PubMed
Summary

Case managers are crucial in preventing Clostridioides difficile infection (CDI) recurrence and rehospitalization through care coordination and patient education. Effective management of CDI transitions improves patient quality of life and reduces severe complications.

More Related Videos

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

27.2K
Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

12.7K

Related Experiment Videos

Last Updated: Aug 26, 2025

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

9.1K
Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

27.2K
Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

12.7K

Area of Science:

  • Infectious Diseases
  • Health Services Research

Background:

  • Clostridioides difficile infection (CDI) is an urgent public health threat, causing significant healthcare utilization and reduced patient quality of life.
  • CDI burden spans all healthcare settings, including community and younger populations, with transitions of care being critical points.
  • Recurrence and rehospitalization rates are increasing, necessitating improved management strategies.

Purpose of the Study:

  • To highlight the role of case managers in preventing CDI recurrence and rehospitalization.
  • To emphasize the need for reducing exposure, supporting treatment, and preventing CDI recurrence.
  • To address the increasing incidence of CDI recurrence and potential for severe complications.

Main Methods:

  • Review of CDI transmission and risk factors in healthcare and community settings.
  • Identification of case manager roles in patient care and transitions.
  • Analysis of strategies to mitigate CDI recurrence and readmission risks.

Main Results:

  • Case managers are essential in preventing CDI recurrence through education, advocacy, and care coordination.
  • Effective transitions of care are vital for reducing CDI recurrence and rehospitalization.
  • Each CDI recurrence increases patient vulnerability to sepsis, surgical intervention, and death.

Conclusions:

  • Case managers play a pivotal role in averting severe CDI complications by managing recurrence through education and care coordination.
  • Mitigating readmission and recurrence risks enhances patient outcomes and quality of life.
  • Case managers facilitate essential support services, addressing barriers like medication costs and appointment access to prevent recurrence.